TUDOR INVESTMENT CORP ET AL

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 923093 STAMFORD, CT

Position in ZNTL

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$81,546

+$34,500 QoQ

Shares Held

34,849

0.0% QoQ

Ownership

0.049%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 50% Shared 50% None 0%

Healthcare · as of Mar 31, 2026

TUDOR INVESTMENT CORP ET AL holds $333,275,952 across 117 Biotechnology names. ZNTL ranks #110 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ACLX	Arcellx, Inc.	462,588	$53,114,354
2	RPRX	Royalty Pharma plc	671,680	$32,220,489
3	XENE	Xenon Pharmaceuticals Inc.	495,591	$28,818,616
4	APLS	Apellis Pharmaceuticals, Inc.	650,000	$26,149,500
5	TERN	Terns Pharmaceuticals, Inc.	267,520	$14,103,654
6	FOLD	AMICUS THERAPEUTICS, INC.	900,000	$13,014,000
7	ABVX	Abivax S.A.	101,611	$11,314,384
8	RVMD	Revolution Medicines, Inc.	87,852	$8,543,607

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$81,546	34,849	0.0%	Shares	Defined	2026-05-15
2025-12-31	$47,046	34,849	0.0%	Shares	Defined	2026-02-17
2025-09-30	$52,621	34,849	0.0%	Shares	Defined	2025-11-14
2025-06-30	$40,424	34,849	0.0%	Shares	Defined	2025-08-14
2025-03-31	$55,409	34,849	-0.9%	Shares	Defined	2025-05-15
2024-12-31	$106,562	35,169	-1.5%	Shares	Defined	2025-02-14
2024-09-30	$131,409	35,709	+1.2%	Shares	Defined	2024-11-14
2024-03-31	$556,375	35,303	+0.2%	Shares	Defined	2024-05-15
2023-09-30	$706,613	35,225	+75.7%	Shares	Defined	2023-11-15
2022-12-31	$403,887	20,054	+29.1%	Shares	Defined	2023-02-14
2022-03-31	$716,600	15,531	-32.9%	Shares	Defined	2022-05-16
2021-12-31	$1,945,232	23,141	-38.5%	Shares	Defined	2022-02-14
2020-09-30	$1,230,059	37,628	—	Shares	Defined	2020-11-16
No filing history on record for this holder in this stock.